Evogene Misses Q1 Estimates with Negative Earnings and Revenue Drop
Evogene reported a GAAP EPS of -$0.60 in the first quarter, missing estimates by $0.33 per share. The company's revenue fell to $0.3 million, down from zero year-over-year, also below expectations. Evogene ended Q1 with approximately $13.1 million in cash and used about $2.8 million during the period.
Tickers: $EVGN